Multiphasic multidetector computed tomographic angiography is a standard diagnostic test for canine abdominal vascular disorders. Three imaging protocols have been previously described.
patients. 2, 10, 11 This protocol is based on the initial injection of a low dose of contrast medium, i.e., test bolus, to determine the peak of aortic and portal enhancement using time attenuations curves followed by a dynamic angiography with a full dose of contrast agent.
This technique has the advantage of being specifically adapted to the patient, which is valuable in animals with impaired cardiovascular function. The bolus-tracking multidetector computed tomographic angiography protocol uses software tools to monitor the arrival of contrast medium into a vessel and triggers an automatic or manual start of the acquisition once the preset density threshold has been reached. This type of protocol provides an individualized timing of the arterial phase. 8, 12, 13 The fixed-injection-duration multidetector computed tomographic angiography protocol is another technique that has been recently described in cats and dogs using a fixed injection duration of 20 s and adjusted injection rate. [14] [15] [16] This new method triggers a later and lower peak of aortic enhancement with good separation between the arterial and portal phases. An advantage of this new technique is a more homogeneous pattern of vascular enhancement regardless of the body weight. Another advantage is a wider temporal window for acquiring the arterial phase.
A previous study compared bolus-tracking and test-bolus techniques for thoracic computed tomographic angiography in healthy beagles and did not identify differences in image quality, consistent with previously published data in human medicine. 17, 18 An increasing number of publications have described multiphasic multidetector computed tomographic angiography protocols for investigations of parenchymal disorders. [5] [6] [7] However, the choice of a particular abdominal multidetector computed tomographic angiography protocol may possibly influence the parenchymal enhancement and have an impact on subsequent results. New multidetector computed tomography (CT) scanners have been recently introduced that have a higher number of detector rows and can therefore offer shorter acquisition times. 19 A detailed comparison of different multidetector computed tomographic angiography protocols was not found in the veterinary literature.
The aim of this study was to compare the conspicuity of vessels in the cranial abdomen using three different protocols of triple-phase multidetector computed tomographic angiography (test-bolus, bolustracking, and fixed-injection-duration protocols). We also aimed to determine which protocol allows the best vascular visualization and to assess the influence of the canine weight and different multidetector CT scanners on the quality of the studies. We hypothesized that there is a difference in vascular conspicuity between the three multidetector computed tomographic angiography protocols and that the quality of these studies depends on the number of detector rows used and body weight.
MATERIALS AND METHODS

Sample population
This retrospective and prospective, multicentric, method comparison study gathered triple-phase abdominal multidetector computed tomographic angiography studies performed on dogs under general anesthesia presented for clinical reasons unrelated to the abdominal vasculature. Decisions for study inclusion and exclusion were made by a final year small animal imaging resident (F.T.). Studies were included if the injection of contrast medium was performed via a cephalic vein and if the arterial, portal and late venous phases included the abdomen from the diaphragm to the caudalmost kidney margin. Dogs were excluded if any vascular impairment or malformation was present in the abdomen.
Images were acquired in ventral recumbency under general anesthesia during apnea following hyperventilation in order to avoid motion artifacts. A precontrast study of the abdomen was acquired in all dogs.
All contrast medium injections were performed with a power injector without the use of saline chaser. All late venous phases were performed within 5 min after contrast medium injection.
Retrospective computed tomographic data
Canine abdominal multidetector computed tomographic angiography studies were retrospectively retrieved from three different institutions. The sample size for each institution group was matched and based on the maximal number of studies available at the University of Edinburgh that fitted the inclusion criteria. Each institution performed one of the three multidetector computed tomographic angiography protocols. As part of the inclusion criteria, the same test-bolus protocol was performed at the Royal (Dick) School of Veterinary Studies of the University of Edinburgh with the following protocol. First, a 0.5 mL/kg bolus of contrast medium (185 mg Iodine/kg) was injected. A dynamic acquisition in a single location at the porta hepatis was performed at the start of the contrast medium injection every 2 s during 40 s.
Regions of interest were placed in the aorta and portal vein by an imaging resident or a board-certified veterinary radiologist. Time attenuation curves were used to establish optimal timings for the arterial and portal acquisitions. The arterial acquisition delay was set at the peak of aortic contrast enhancement. The minimum interscan delay was 4 s. The portal delay was initiated shortly before peak portal enhancement or following the minimum reset time between two phases. The full bolus of contrast medium (700-740 mg I/kg) was injected at 3 mL/s in dogs weighing less than 10 kg and at 5 mL/s if over 10 kg as per previous publication. 10 The arterial phase was performed in a caudo-cranial direction, the portal and late venous phase were scanned in a craniocaudal direction.
The bolus-tracking protocol was performed at the Istituto Veterinario di Novara. As part of the inclusion criteria, the following protocol was used. A premonitoring transverse scan was set at the cranial aspect of the diaphragm, and designated as the start location of the arterial acquisition. A region of interest was placed in the aorta by an imaging resident, and the automated bolus-tracking set at 100
Hounsfield units (HU) with a cycle time of 3 s. The bolus of contrast medium (700 mg I/kg) was performed in all dogs at 3 mL/s. The arterial phase was run in a cranio-caudal direction, the portal phase scanned immediately after the minimum reset time in a caudo-cranial direction and the late venous phase in a cranio-caudal direction. The minimum interscan delay was 2 s.
The fixed-injection-duration protocol was performed at the University of Sydney. As part of the inclusion criteria, the following protocol was followed. Bolus-tracking software and fixed delay times after contrast arrival were used for the arterial and portal scans. Contrast medium was injected over 20 s for all dogs and the injection rate was adjusted accordingly. A pre-monitoring transverse scan was set at the cranial aspect of the diaphragm. A region of interest was placed in the aorta by an imaging resident and the automated bolus-tracking set at 100 HU with a cycle time of 2 s. The time-to-aortic-arrival was defined as the time elapse from the beginning of the contrast medium injection to the time when the aortic attenuation reached 100 HU. The delay for arterial acquisition was similar for all dogs and equal to 10 s after time-to-aortic-arrival in order to scan during the arterial peak or immediately after. The minimum interscan delay was 2 s. The portal acquisition was automatically triggered 35 s after time-to-aortic-arrival. The arterial phase was run in a cranio-caudal direction, the portal phase scanned in a caudo-cranial direction, and the late venous phase in a cranio-caudal direction. 
Prospective computed tomographic data
Computed tomographic data recorded
All retrospective multidetector computed tomographic angiography studies were randomized, reviewed by a board-certified veterinary radiologist (T.S.) and an imaging resident (F.T.), and scored by consensus. All studies were anonymized and reviewers were blinded to the angiographic protocol used. All assessments and measurements were performed using dedicated DICOM viewer software (OsiriX v5.8. Models were assessed by inspection of histograms of their residuals.
Data analyses
Summary estimates of the relationship between protocol and index F I G U R E 1 Optimal arterial phase illustrated by a transverse plane for each abdominal region (A-C) in a dog using the bolus-tracking protocol on 64-row multidetector computed tomography unit. Note the strong contrast enhancement in the aorta, celiac and hepatic arteries (arrows) but none in the portal and venous vasculature (arrowheads)
were estimated using the Least-Squares means (Lsmeans) R-package and reported as estimate and 95% confidence interval. In order to investigate any difference of scan duration between four-and 16-slice CT units, a Kruskal-Wallis test was performed. The significance level for statistical tests was set at 0.05. for the fixed-injection-duration protocol. Duration of the arterial and portal scans is summarized in Figure 3 . The total scan duration was not significantly different between the four-slice CT scanner and both 16-slice CT units (n = 30, df = 2, 2 = 4.43, P = 0.109). These scanners were therefore grouped together in the following linear regression models.
RESULTS
Retrospective computed tomographic data
The mean indices are summarized in Table 1 . During the arterial phase, the fixed-injection-duration protocol had the narrowest dispersion of data. Quantitatively, the arterial phase of the test-bolus protocol had the highest mean arterial index compared to the other two protocols, while the portal phase of the fixed-injection-duration protocol offered the highest mean portal index. Overall, the fixed-injectionduration protocol has the highest mean combined vascular index and narrowest dispersion of data.
On the arterial phase of the fixed-injection-duration protocol, contrast enhancement was visible in the portal vein at the porta hepatis in nine of 10 dogs consistent with a late arterial acquisition. In the testbolus group during the portal phase, contrast streaming artifact was reported in the portal vein in four dogs and in the caudal vena cava in six dogs. This artifact was less commonly noted in the bolus-tracking group (2/10 dogs) and the fixed-injection-duration group (4/10 dogs) during the portal phase.
During the arterial phase, the mean aortic attenuation was quantitatively higher for the test-bolus protocol compared to the bolustracking and fixed-injection-duration protocols ( Table 2 ). These two last protocols nevertheless achieved acceptable aortic enhancement.
During the portal phase, the mean aortic attenuation was lower for the fixed-injection-duration protocol compared to the test-bolus and bolus-tracking protocols.
Prospective computed tomographic data
Various breeds were represented among which Retrievers mean bolus-tracking portal index, on the other hand, was lower than the two other protocols due to a very premature acquisition. Overall, the test-bolus protocol had the highest mean combined vascular index.
On the arterial phase of the fixed-injection-duration protocol, contrast enhancement was visible in the portal vein at the porta hepatis in five of dogs consistent with a late arterial acquisition. In the bolus-tracking group during the portal phase, contrast streaming artifact was present in the portal vein in all seven dogs and in the caudal vena cava in five dogs ( Figure 4 ). This artifact remained common in the test-bolus group (4/7 dogs) but was never present in the studies of the fixed-injection-duration group during the portal phase.
During the arterial phase, the mean attenuation in the portal vein and caudal vena cava was quantitatively higher for the fixed-injectionduration protocol compared to the other two protocols, consistent with a late arterial acquisition (Table 2) . During the portal phase, the mean aortic attenuation was quantitatively lower for the fixedinjection-duration protocol compared to the test-bolus and bolustracking protocols.
Linear regression model for combined vascular index
The factor scan duration was found to be non-significant and strongly correlated to the scanner type ( = 0.836). This factor was dropped from initial model, which was then re-estimated. 
Separated linear regression models for arterial and portal phases
Similarly, the factor scan duration was found to be non-significant and strongly correlated to the scanner type ( = 0.815 for the arterial phase TA B L E 2 Vascular contrast attenuation in Hounsfield units during the arterial and portal phase for each protocol and multidetector computed tomography scanner Abbreviation: MDCT; multiphasic multidetector computed tomography, SD; standard deviation.
Test-bolus protocol
Bolus-tracking protocol
Fixed-injection-duration protocol
F I G U R E 4
Portal phase in a dog using the bolus-tracking protocol on a 64-row multidetector computed tomography unit. Note the contrast streaming artifact in the portal vein (arrowhead) due to arrival of unenhanced blood from the splenic vein (arrow) and = 0.857 for the portal phase). This factor was dropped from initial models, which were then re-estimated. 
DISCUSSION
Findings from this study support our primary hypothesis in that there was a difference of vascular conspicuity between protocols during the arterial and portal phase in the separated linear regression model. The quality of arterial studies performed on the 64-row multidetector CT scanner was improved compared to the ones performed on four-to 16-row multidetector CT scanners. This effect was not demonstrated during the portal phase. Contrary to our last hypothesis, body weight had no effect on image quality.
The lack of difference in overall vascular conspicuity between the different protocols in the combined linear regression model does not fully reflect the more detailed results for each vascular phase. In fact, the test-bolus and bolus-tracking protocols provided arterial studies of better quality than the fixed-injection-duration protocol while it was the contrary during the portal phase, and these effects cancelled each other out. In order to interpret the specificity of each protocol during each phase, we chose to focus the rest of our discussion based on the separated linear regression model. Our hypothesis that image quality depends on the number of detector rows of a CT scanner was confirmed for the arterial phase but not for the portal phase. The arterial phase was of higher quality on a 64-row MDCT scanner. Indeed, a low number of detector rows represents a limitation to the scanner speed. By increasing detector row numbers in multidetector CT, scanning time is reduced, and thus, the image quality is more homogeneous for each vascular phase. 19 On fast CT units, bolus-tracking software is optimal to trigger an arterial phase of excellent quality as shown in this study. In practice, on MDCT scanners with a low number of detector rows, the portal phase of the bolustracking protocol can be run immediately after the arterial phase and result in a study of acceptable quality. Unfortunately, if the exact same protocol is run on a fast multidetector CT unit, like in the prospective part of this study, it will trigger a very premature portal phase. The absence of optimal portal timings explains the overall low quality of the portal phase using the bolus-tracking protocol on 64-row multidetector CT scanner. Previous publications have established optimal delays using bolus-tracking technique for the pancreas and liver, although the need for organ-specific delays is not practical for daily use. 8, 13 Weight is another variable that has to be taken into account for the bolustracking protocol since the time-to-arterial peak is influenced by body weight when the injection rate is fixed. 14 The bolus-tracking protocol needs to be adapted for fast multidetector CT scanners with a high number of detector rows by establishing longer delays between the arterial and portal phases.
Depending on the protocol and the multidetector CT scanner used, studies had wide to narrow variation of quality. Overall, the fixedinjection-duration and the bolus-tracking protocol presented the narrowest data dispersion for all phases combined. These two protocols are therefore better reproducible compared to the test-bolus technique. This finding may be related to human errors. Indeed, for the test-bolus protocol, the operator has to select the optimal timings on the time-attenuation curves of the test bolus, which is often done by observing a graph, rather than using displayed time The fixed-injection-duration protocol was designed to suppress the variability of vascular enhancement due to weight and to have a wide temporal window to acquire the arterial phase. 14 A slow injection of contrast medium over 20 s triggers a later and lower aortic peak enhancement due its wider bolus geometry. [14] [15] [16] 21 On four-and 16-row multidetector CT scanners, the aortic attenuation during the arterial phase was indeed lower compared to the test-bolus protocol but higher than the bolus-tracking protocol. On 64-row multidetector CT scanner, the three protocols had similar aortic attenuation during the arterial phase. The bolus-tracking protocol had nevertheless a wide distribution of data for the aortic attenuation. For a fixed injection rate, the time to arterial peak is influenced by body weight. 14 A short acquisition time thus increases the variability of aortic attenuations between dogs of different body weights. Overall, the choice of protocol for the arterial phase appears to have little impact on the aortic contrast enhancement. During the portal phase, however, the aortic contrast enhancement was lower with the fixed-injection-duration protocol. This is most likely due to a later portal acquisition compared to the other two protocols.
Surprisingly, the scan duration had no effect on vascular conspicuity in this study. It has been suggested that contrast medium injection rate should be increased with fast CT acquisition in order to match the fast scanning duration. 16, 19 The disadvantage of decreasing the injection duration is the narrowing of the temporal window for the arterial scan. Given the good quality of the portal phase of the fixed-injection-duration protocol, we therefore recommend to keep a long injection duration of 20 s for this protocol.
Contrast streaming artifact was commonly reported in earlyperformed portal studies. Non-contrast enhanced blood of the splenic vein mixes with contrast-enhanced blood in the portal vein and causes this artifact when the portal phase is performed too early. In the caudal vena cava, contrast streaming artifact is visible when early renal contrast-enhancing venous flow mixes with non-enhancing caval blood. In the authors' opinion, streaming artifact in the caudal vena cava or portal vein can be considered as a good marker of a premature portal phase. In the test-bolus group, 11/17 studies demonstrated this vascular artifact during the portal phase while it was rarely noted in the fixed-injection-duration group. On a 64-row multidetector CT unit, the portal phases of the bolus-tracking group were all performed too early, which was confirmed by the low portal index and commonly reported contrast streaming artifact.
Due to the multicentric nature of the study, different MDCT scan- 
